Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	214	241	332	432	517	643
Market Cap Growth	-27.34%	-27.34%	-23.28%	-16.40%	-19.60%	-13.05%
Enterprise Value	185	206	290	376	447	567
Last Close Price	15.11	16.46	22.66	29.60	35.83	45.26
PE Ratio	-	-	-	-	125.13	-
Forward PE	48.74	39.19	-	-	-	62.00
PS Ratio	1.86	2.01	2.75	3.80	3.50	4.93
PB Ratio	1.41	1.57	1.56	1.51	1.80	2.36
P/TBV Ratio	1.67	1.67	1.64	2.12	2.63	3.72
P/FCF Ratio	-	-	-	158.96	56.25
P/OCF Ratio	39.64	44.62	-	98.08	61.60	49.24
PEG Ratio	2.44	-	-	-	161.40	3.10
EV/Sales Ratio	1.54	1.72	2.40	3.30	3.03	4.34
EV/EBITDA Ratio	50.88	56.88	18.37	20.70	194.39	151.74
EV/EBIT Ratio	-	182.42	102.39	-	-
EV/FCF Ratio	-	-	-	137.51	49.55
Debt / Equity Ratio	0.17	0.17	0.13	0.11	0.07	0.08
Debt / EBITDA Ratio	3.48	3.48	1.42	1.44	4.12	3.52
Debt / FCF Ratio	-	-	-	-	6.44	1.96
Asset Turnover	0.51	0.51	0.39	0.33	0.41	0.38
Inventory Turnover	1.80	1.80	1.17	1.07	1.42	1.80
Quick Ratio	3.40	3.40	3.06	4.33	4.17	3.32
Current Ratio	4.88	4.88	5.26	6.07	5.66	4.81
Return on Equity (ROE)	-4.82%	-4.82%	-1.38%	0.77%	1.48%	-8.55%
Return on Assets (ROA)	-1.19%	-1.19%	0.32%	0.66%	-2.11%	-1.75%
Return on Capital (ROIC)	-1.34%	-1.34%	0.36%	0.73%	-2.49%	-2.01%
Return on Capital Employed (ROCE)	-	-	0.70%	1.10%	-	-
Earnings Yield	-26.32%	-23.39%	-24.92%	-3.44%	0.80%	-3.73%
FCF Yield	-1.09%	-0.97%	-2.17%	-0.71%	0.63%	1.78%
Buyback Yield / Dilution	-0.44%	-0.44%	-0.65%	0.50%	-2.90%	1.06%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q